Vulnerabilities

Vulnerability · CVE-2026-2695

A command injection vulnerability was discovered in TeamViewer DEX Platform On-Premises (former 1E DEX Platform On-Premises) prior to version 9.2.

Published May 13, 2026 · catalog updated Jun 17, 2026 · A command injection vulnerability

Check if you run it

No confirmed exploitation is on record for CVE-2026-2695. EPSS is 0.34%. Act only if a listed version of A command injection vulnerability is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (A command injection vulnerability).
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium6.3
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.34%
Remediation
Advisory link
Affected products
See sources for product scope

A command injection vulnerability was discovered in TeamViewer DEX Platform On-Premises (former 1E DEX Platform On-Premises) prior to version 9.2. Improper input validation allows authenticated users with at least questioner privileges to inject commands in specific instructions. Exploitation could lead to execution of elevated commands on devices connected to the platform.

No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.

How to fix CVE-2026-2695

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-2695. EPSS is 0.34%. Act only if a listed version of A command injection vulnerability is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-20: Improper Input Validation. EPSS 0.34%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. May 13, 2026 · NIST NVD

    Detected

    A command injection vulnerability was discovered in TeamViewer DEX Platform On-Premises (former 1E DEX Platform On-Premises) prior to version 9.2. Improper input validation allows authenticated users with at least questioner privileges to inject commands in specific instructions. Exploitation could lead to execution of elevated commands on devices connected to the platform.

  2. Jun 17, 2026 · NIST NVD

    Updated

    A command injection vulnerability was discovered in TeamViewer DEX Platform On-Premises (former 1E DEX Platform On-Premises) prior to version 9.2. Improper input validation allows authenticated users with at least questioner privileges to inject commands in specific instructions. Exploitation could lead to execution of elevated commands on devices connected to the platform.

Sources

  • CVE.orgVulnerability recordCVE-2026-2695

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-2695

    30-day exploitation probability 0.3%

    first.org
  • NIST NVDVulnerability recordCVE-2026-2695

    A command injection vulnerability was discovered in TeamViewer DEX Platform On-Premises (former 1E DEX Platform On-Premises) prior to version 9.2. Improper input validation allows authenticated users with at least questioner privileges to inject commands in specific instructions.

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.